Sensori-motor neurofeedback improves inhibitory control and induces neural changes: a placebo-controlled, double-blind, event-related potentials study

被引:1
|
作者
Dousset, Clemence [1 ]
Wyckmans, Florent [1 ]
Monseigne, Thibaut [2 ]
Fourdin, Laureline [3 ]
Boulanger, Romane [3 ]
Sistiaga, Sonia [1 ]
Ingels, Anais [1 ]
Kajosch, Hendrik [1 ]
Noel, Xavier [1 ]
Kornreich, Charles [1 ]
Campanella, Salvatore [1 ]
机构
[1] CHU Brugmann Univ Libre Bruxelles ULB, ULB Neurosci Inst UNI, Lab Med Psychol & Addictol, 4 Pl Vangehuchten, B-1020 Brussels, Belgium
[2] Univ Bordeaux, SANPSY, CNRS, USR 3413, Bordeaux, France
[3] Univ Libre Bruxelles ULB, Ctr Res Cognit & Neurosci CRCN, ULB Neurosci Inst UNI, 50 Ave Franklin Roosevelt,CP191, B-1050 Brussels, Belgium
关键词
Event-related potential; Neurofeedback; Sensori-motor rhythm; Cognitive inhibitory control; NETWORKS; SLEEP;
D O I
10.1016/j.ijchp.2024.100501
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background/Objective: Inhibition is crucial for controlling behavior and is impaired in various psychopathologies. Neurofeedback holds promise in addressing cognitive deficits, and experimental research is essential for identifying its functional benefits. This study aimed to investigate whether boosting sensorimotor activity (SMR) improves inhibitory control in a final sample of healthy individuals (N = 53), while exploring the underlying neurophysiological mechanism. Method: Participants were randomly divided into two groups: one receiving SMR neurofeedback training to enhance sensorimotor activity within the 12-15 Hz frequency range, and the other receiving sham feedback. Inhibition performance and neural correlates were evaluated with a Go-NoGo task before (T0) and after (T1) 10 neurofeedback sessions using event-related potentials. Data were analyzed via ANOVAs and regression analyses. Results: Compared to placebo, the active group demonstrated higher absolute SMR power (p = 0.040) and improvements in inhibitory control, including faster response times and fewer inhibition errors (p < 0.001, d = 6.06), associated with a larger NoGoP3d amplitude (p < 0.001, d = 3.35). A positive correlation between the increase in SMR power and the rise in NoGoP3d amplitude (beta=0.46, p = 0.015) explains 21 % of the observed variance. Conclusions: Uptraining SMR power is linked to heightened utilization of neural resources for executing optimal inhibition responses. These results uphold its effectiveness in cognitive rehabilitation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] No changes in event-related potentials with estrogen or estrogen plus progesterone treatment in healthy older hysterectomized women: results from a double-blind, placebo-controlled study
    V. Walpurger
    R. Pietrowsky
    S. Djahansouzi
    O. T. Wolf
    Psychopharmacology, 2005, 179 : 652 - 661
  • [2] No changes in event-related potentials with estrogen or estrogen plus progesterone treatment in healthy older hysterectomized women: results from a double-blind, placebo-controlled study
    Walpurger, V
    Pietrowsky, R
    Djahansouzi, S
    Wolf, OT
    PSYCHOPHARMACOLOGY, 2005, 179 (03) : 652 - 661
  • [3] NEUROFEEDBACK BALANCE TRAINING IN THE PREVENTION OF FALLS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Basta, D.
    Ernst, A.
    GERONTOLOGIST, 2013, 53 : 329 - 330
  • [4] TOPOGRAPHIC MAPPING OF COGNITIVE EVENT-RELATED POTENTIALS IN A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH THE HEMODERIVATIVE ACTOVEGIN IN AGE-ASSOCIATED MEMORY IMPAIRMENT
    SEMLITSCH, HV
    ANDERER, P
    SALETU, B
    HOCHMAYER, I
    NEUROPSYCHOBIOLOGY, 1991, 24 (01) : 49 - 56
  • [5] TOPOGRAPHIC MAPPING OF LONG LATENCY COGNITIVE EVENT-RELATED POTENTIALS (P-300) - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AMANTADINE IN MILD DEMENTIA
    SEMLITSCH, HV
    ANDERER, P
    SALETU, B
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1992, 4 (04) : 319 - 336
  • [6] ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study
    M. M. Lansbergen
    M. van Dongen-Boomsma
    J. K. Buitelaar
    D. Slaats-Willemse
    Journal of Neural Transmission, 2011, 118 : 275 - 284
  • [7] Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia
    Schabus, Manuel
    Griessenberger, Hermann
    Gnjezda, Maria-Teresa
    Heib, Dominik P. J.
    Wislowska, Malgorzata
    Hoedlmoser, Kerstin
    BRAIN, 2017, 140 : 1041 - 1052
  • [8] ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study
    Lansbergen, M. M.
    van Dongen-Boomsma, M.
    Buitelaar, J. K.
    Slaats-Willemse, D.
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (02) : 275 - 284
  • [9] Efficacy of cabergoline for the treatment of sensori-motor symptoms and sleep disturbances in restless legs syndrome: A placebo-controlled, 5-week, double-blind, randomized, multicenter, polysomnographic study
    Oertel, WH
    Benes, H
    Happe, S
    Kohnen, R
    Leroux, M
    Stiasny-Kolster, K
    MOVEMENT DISORDERS, 2004, 19 : S425 - S425
  • [10] Creatine supplementation improves performance, but is it safe? Double-blind placebo-controlled study
    Almeida, Douglas
    Colombini, Alessandra
    Machado, Marco
    JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS, 2020, 60 (07): : 1034 - 1039